Consistently, the changes observed in plasma YKL-40 levels replicated at the protein level our previous expression analyses using primary osteoblasts obtained from AIS patients and matched healthy controls (Supplementary Fig. 1). This evidence concerns the gene CHI3L1 and androgen insensitivity syndrome.